Barrington Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $114
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target
Merit Medical Systems Analyst Ratings
CCORF Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $127
Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $109
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)
Wells Fargo Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $120
BofA Securities Maintains Merit Medical Systems(MMSI.US) With Hold Rating, Maintains Target Price $103
Merit Medical Raised to Overweight From Equal-Weight by Wells Fargo
Wells Fargo Upgrades Merit Medical Systems(MMSI.US) to Buy Rating, Raises Target Price to $120
Merit Medical Is Maintained at Buy by Canaccord Genuity
Merit Medical Systems Analyst Ratings
CCORF Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $127
A Quick Look at Today's Ratings for Merit Medical Systems(MMSI.US), With a Forecast Between $109 to $125
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target
Merit Medical Is Maintained at Outperform by Baird
Merit Medical Systems Analyst Ratings
Baird Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $109
Piper Sandler Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $110
Piper Sandler Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $110